Expertos en visión artificialen adquisición de imágenes /procesamiento / inteligencia artificial.
CEOS will attend the International Paris Air Show at le Bourget 2019.
ADCIS & EVOLUCARE choose the SFO International Congress to seal their alliance through the creation of OphtAI Joint-Venture.
From April 28th to May 2nd, 2019, ADCIS attented the Annual Convention of the Association for Research in Vision and Ophthalmology (ARVO) in Vancouver, Canada.
ADCIS in collaboration with L’Oreal attended at the International Symposium on Biomedical Imaging (ISBI) in Venice, Italy Paris, which held on April 8th to 11th, 2019.
Mrs HAIZE-HAGRON, Director of AdC, decided to participate to the project to find a solution for the monitoring of the airport.
ADCIS attended at the National Congress of the Francophone Diabetes Society held at Parc Chanot in Marseille from 26th to 29th March 2019.
The new version of the EyePrint Designer (EPD) Software has been presented at the GSLS 2019 Symposium.
Introduced at CES’2019, the innovation named OphtAI is an artificial intelligence resulting from three years of collaborative research between researchers, clinicians, and manufacturers.
At Ophthalmology 2018 in Moscow, Russia, Bruno Laÿ, ADCIS CEO, presented a joint work with Fondation Rothschild, the “3D Image processing and image display of the vascular network in OCT-Angiography Images”.
Copyright © 2024 ADCIS SAS
